Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Research output: Contribution to journalJournal articlepeer-review

Original languageEnglish
JournalThe Lancet Diabetes & Endocrinology
Volume8
Issue number4
Pages (from-to)313-324
Number of pages12
ISSN2213-8587
DOIs
Publication statusPublished - 2020

ID: 239075974